Comparison between central and ambulatory blood pressure measurements in early detection of end organ damage: a single-center prospective non-randomized controlled trial

The Egyptian Heart Journal

Table 3 Relation between SBP measured by different tools monitoring and early hypertensive end organ damage

	ABPM		P value	Central		P value
	Controlled	Not controlled		Controlled	Not controlled
	No. (%)	No. (%)		No. (%)	No. (%)
ECG
Normal	48 (96%)	13 (26%)	0.000**	49 (90.7%)	12 (26.1%)	0.000**
LVH	2 (4%)	34 (68%)		5 (9.3%)	31 (67.4%)
LBBB	0 (0%)	3 (6%)		0 (0%)	3 (6.5%)
LVMI
Normal	47 (94%)	37 (74%)	0.006**	52 (96.3%)	32 (69.6%)	0.000**
Abnormal	3 (6%)	13 (26%)	0.006**	2 (3.7%)	14 (30.4%)	0.000**
CIMT
Normal	47 (94%)	37 (74%)	0.006**	51 (94. 4%)	33 (71.7%)	0.002**
Abnormal	3 (6%)	13 (26%)	0.006**	3 (5. 6%)	13 (28.3%)	0.002**
PWV
Normal	50 (100%)	43 (86%)	0.006**	54 (100%)	39 (84.8%)	0.003**
Abnormal	0 (0%)	7 (14%)	0.006**	0 (0%)	7 (15. 2%)	0.003**
ABI
Normal	39 (78%)	21 (42%)	0.000**	41 (75.9%)	19 (41.3%)	0.000**
Abnormal	11 (22%)	29 (58%)	0.000**	13 (24.1%)	27 (58.7%)	0.000**
Creatinine
Normal	47 (94%)	30 (60%)	0.000**	52 (96.3%)	25 (54.3%)	0.000**
Abnormal	3 (6%)	20 (40%)	0.000**	2 (3.7%)	21 (45.7%)	0.000**
GFR
Normal	47 (94%)	36 (72%)	0.003**	50 (92.6%)	33 (71.7%)	0.006**
Abnormal	3 (6%)	14 (28%)	0.003**	4 (7.4%)	13 (28.3%)	0.006**

Chi-square test
*Statistically significant difference (p < 0.05)
**Highly statistically significant difference (p < 0.01)
HTN hypertension, ABPM ambulatory blood pressure monitoring, PWV pulse wave velocity, Cr creatinine, GFR glomerular filtration ratio, LVMI left ventricular mass index, CIMT carotid intimal thickness, ABI ankle-brachial index